Spencer Laird is the second patient at Duke Cancer Clinic to undergo immunotherapy treatment for stage 4 colon cancer ...

A 26-year-old is now "cancer-free" after receiving a new treatment for colorectal cancer. "I was declared cancer free in July ...

Agenus (NASDAQ:AGEN) used its March stakeholder webcast to highlight progress for its investigational immunotherapy ...

A new study from researchers at the Alliance for Clinical Trials in Oncology (Alliance) shows that patients with stage III ...

Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped ...

ROCHESTER, Minn. — A new treatment combining immunotherapy with chemotherapy after surgery cut the risk of cancer coming back ...

A study shows adding immunotherapy to chemotherapy after surgery reduces recurrence and death by half in dMMR stage three ...

Colorectal cancer is the third most common cancer worldwide. It is estimated that there are over 1.5 million diagnoses a year. Specifically, in the United States, there is estimated to have over ...

Colorectal cancer, or cancer of the bowel or rectum, has long been associated with older adults. However, in recent years, ...

Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to ...

Colorectal cancer has become the deadliest cancer for adults under 50 years old in the United States, and it's becoming more prominent in Missouri. According to data from the American Cancer Society, ...